| 1 | 81525-10-2 | 萘莫司他 | Nafamostat | C19H17N5O2
| 药物;黄金产品;生物化工;杂质对照品;抗胰腺炎药物;消化系统用药;合成材料中间体;原料药及中间体 | |
| 2 | 371934-59-7 | PIK-inhibitors | PIK-inhibitors | C19H17N5O2
| 对照品 | |
| 3 | | BUTTPARK 130\40-27 | BUTTPARK 130\40-27 | C19H17N5O2
| | |
| 4 | 1372048-27-5 | N2,N6-bis(4-aminophenyl)pyridine-2,6-dicarboxamide | N2,N6-bis(4-aminophenyl)pyridine-2,6-dicarboxamide | C19H17N5O2
| | |
| 5 | 876755-52-1 | 9-[(3-{4-nitro-1H-imidazol-1-yl}propyl)amino]acridine | 9-[(3-{4-nitro-1H-imidazol-1-yl}propyl)amino]acridine | C19H17N5O2
| | |
| 6 | 116044-30-5 | 2,6-'吡啶二甲酰胺',N2,N6-'双(2-'吡啶基甲基)- | 2-N,6-N-bis(pyridin-2-ylmethyl)pyridine-2,6-dicarboxamide | C19H17N5O2
| | |
| 7 | | N,1-DIBENZYL-5-(CYANOMETHOXY)-1H-1,2,3-TRIAZOLE-4-CARBOXAMIDE | N,1-DIBENZYL-5-(CYANOMETHOXY)-1H-1,2,3-TRIAZOLE-4-CARBOXAMIDE | C19H17N5O2
| | |
| 8 | 712297-57-9 | 6,7-dimethoxy-4-methyl-3-(1-phenyl-1H-tetraazol-5-yl)quinoline | 6,7-dimethoxy-4-methyl-3-(1-phenyl-1H-tetraazol-5-yl)quinoline | C19H17N5O2
| | |
| 9 | 393786-56-6 | N-(3,4-dimethoxyphenyl)-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine | N-(3,4-dimethoxyphenyl)-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine | C19H17N5O2
| | |
| 10 | 303787-29-3 | 4-[2-(4,6-dimethyl-2-pyrimidinyl)carbohydrazonoyl]phenyl isonicotinate | 4-[2-(4,6-dimethyl-2-pyrimidinyl)carbohydrazonoyl]phenyl isonicotinate | C19H17N5O2
| | |
| 11 | 1133444-09-3 | 4(3H)-Quinazolinone, 2-[(6-methoxy-4-methyl-2-quinazolinyl)amino]-5-methyl- | 4(3H)-Quinazolinone, 2-[(6-methoxy-4-methyl-2-quinazolinyl)amino]-5-methyl- | C19H17N5O2
| | |
| 12 | 457951-32-5 | benzyl 5-methyl-7-phenyl-4,7-dihydrotetrazolo[1,5-a]pyrimidine-6-carboxylate | benzyl 5-methyl-7-phenyl-4,7-dihydrotetrazolo[1,5-a]pyrimidine-6-carboxylate | C19H17N5O2
| | |
| 13 | | benzyl 5-methyl-7-phenyl-4,7-dihydrotetraazolo[1,5-a]pyrimidine-6-carboxylate | benzyl 5-methyl-7-phenyl-4,7-dihydrotetraazolo[1,5-a]pyrimidine-6-carboxylate | C19H17N5O2
| | |
| 14 | | 3,3a,4,5-Tetrahydro-4-oxo-2,7-diphenylpyrazolo[1,5-d][1,2,4]triazine-5-acetamide | 3,3a,4,5-Tetrahydro-4-oxo-2,7-diphenylpyrazolo[1,5-d][1,2,4]triazine-5-acetamide | C19H17N5O2
| | |
| 15 | | 3-Methyl-10-[4-(dimethylamino)phenyl]pyrimido[4,5-b]quinoxaline-2,4(3H,10H)-dione | 3-Methyl-10-[4-(dimethylamino)phenyl]pyrimido[4,5-b]quinoxaline-2,4(3H,10H)-dione | C19H17N5O2
| | |
| 16 | 518018-85-4 | (E)-3-(1H-benzo[d]imidazol-1-yl)-2-methyl-N-(2-oxoindolin-3-ylidene)propanehydrazide | (E)-3-(1H-benzo[d]imidazol-1-yl)-2-methyl-N-(2-oxoindolin-3-ylidene)propanehydrazide | C19H17N5O2
| | |
| 17 | 82956-09-0 | Benzoic acid, 3-[(aminoiminomethyl)amino]-, 6-(aminoiminomethyl)-2-naphthalenyl ester | Benzoic acid, 3-[(aminoiminomethyl)amino]-, 6-(aminoiminomethyl)-2-naphthalenyl ester | C19H17N5O2
| 杂质对照品;158-萘莫司他 | 158-萘莫司他;杂质对照品 |
| 18 | 329796-08-9 | 7-(4-hydroxyphenyl)-5-methyl-N-phenyl-4,7-dihydro[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxamide | 7-(4-hydroxyphenyl)-5-methyl-N-phenyl-4,7-dihydro[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxamide | C19H17N5O2
| | |
| 19 | | 6-AMINO-2,5-BIS(4-METHYLPHENYL)-4-OXO-4,5-DIHYDRO-2H-[1,2,3]TRIAZOLO[1,5-A]PYRAZIN-8-IUM-3-OLATE | 6-AMINO-2,5-BIS(4-METHYLPHENYL)-4-OXO-4,5-DIHYDRO-2H-[1,2,3]TRIAZOLO[1,5-A]PYRAZIN-8-IUM-3-OLATE | C19H17N5O2
| | |
| 20 | 724739-20-2 | 1,9-dimethyl-4-oxo-N-(3-pyridinylmethyl)-1,4-dihydropyrido[1,2-a]pyrrolo[2,3-d]pyrimidine-2-carboxamide | 1,9-dimethyl-4-oxo-N-(3-pyridinylmethyl)-1,4-dihydropyrido[1,2-a]pyrrolo[2,3-d]pyrimidine-2-carboxamide | C19H17N5O2
| | |
| 21 | | (4E)-2-(1H-BENZIMIDAZOL-2-YL)-4-{[(4-METHOXYPHENYL)AMINO]METHYLENE}-5-METHYL-2,4-DIHYDRO-3H-PYRAZOL-3-ONE | (4E)-2-(1H-BENZIMIDAZOL-2-YL)-4-{[(4-METHOXYPHENYL)AMINO]METHYLENE}-5-METHYL-2,4-DIHYDRO-3H-PYRAZOL-3-ONE | C19H17N5O2
| | |
| 22 | 847035-00-1 | 6-amino-3-ethyl-2,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile-4-spiro-3'-(1'-allyl-1',3'-dihydro-2'H-indol-2'-one) | 6-amino-3-ethyl-2,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile-4-spiro-3'-(1'-allyl-1',3'-dihydro-2'H-indol-2'-one) | C19H17N5O2
| | |